The DOI matches its OpenAlex record; 9 of the 9 references it cites were found in a registry or an index.
The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell's Syndrome)
Abstract
Between 1972 and 1985, 87 patients with toxic epidermal necrolysis (TEN) were admitted to the dermatological intensive care unit at Hôpital Henri Mondor, Créteil, France. The culpable drug was determined by standardized criteria. Only three patients had received no drugs before the onset of TEN. Most patients (71 of 87) were receiving more than one drug. Patients had taken an average of 4.4 +/- 3.4 drugs each. A culpable drug was determined in 67 patients (77%). The mean time from first drug administration to onset of TEN was 13.6 +/- 8.4 days. The culprit drugs included the following: sulfonamides, 18 cases, and especially sulfamethoxazole and trimethoprim, 12; anticonvulsants, seven (barbiturates and carbamazepine only); nonsteroidal anti-inflammatory drugs, 29 (especially the phenylbutazone derivative, 16, and oxicam derivatives, 10); allopurinol, three; chlormezanone, three; and others, seven. Aspirin, antipyretics, and antibiotics are infrequently implicated in this series. The pattern of culprit drugs changed with years. The level of sulfonamide-related TEN remained the same, while incidence of nonsteroidal anti-inflammatory drug-induced TEN increased sharply, the introduction of oxicam derivatives being in part responsible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bégaud, B., Evreux, J. C., Jouglard, J., et al. (1985) · PubMed · Cited by 840
Toward the operational identification of adverse drug reactions
Karch, F. E., & Lasagna, L. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977213247 · Cited by 460
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients
Revuz, J. E. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1160 · Cited by 395
Kramer, M. S. (1979) · JAMA · doi:10.1001/jama.1979.03300070019017 · Cited by 346
Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty cases
Ruiz-Maldonado, R. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70207-1 · Cited by 164
Etiologic Factors of the Stevens-Johnson Syndrome
Yetiv, J. Z., Bianchine, J. R., & OWEN, J. A. (1980) · Southern Medical Journal · doi:10.1097/00007611-198005000-00015 · Cited by 115
Observations on drug-induced toxic epidermal necrolysis in Singapore
Chan, H. L. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80317-5 · Cited by 74
STEVENS-JOHNSON SYNDROME AFTER MASS PROPHYLAXIS WITH SULFADOXINE FOR CHOLERA IN MOZAMBIQUE
Hernborg, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90945-6 · Cited by 62
Cited by
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Sassolas, B., Haddad, C., Mockenhaupt, M., Dunant, A., Liss, Y., Bork, K., Haustein, U. F., Vieluf, D., Roujeau, J. C., & Le Louet, H. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.252 · Cited by 758
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany
Schöpf, E. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050083008 · Cited by 399
Epidemiology and risk factors for drug allergy
Thong, B. Y., & Tan, T. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03774.x · Cited by 393
Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985
Roujeau, J. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.1.37 · Cited by 391
Metadata
- Authors
- Guillaume, J. C.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association
- Published
- 1987-09-01
- Volume
- 123
- Issue
- 9
- Pages
- 1166-1166
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2040099759
- Cited by
- 257
- References
- 9
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell's Syndrome). https://app.cochat.ai/papers/10.1001/archderm.123.9.1166
- The paper
- Guillaume, J. C. (1987). The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell's Syndrome). Archives of Dermatology. https://doi.org/10.1001/archderm.123.9.1166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.